Overview
Status
Active
Registry date
2021-05-26
Share capital
5,000.00 PLN
Registered address
ul. Jerzego Bajana 7/1, 54-129 Wrocław, Poland
Electronic delivery address
AE:PL-10003-27919-DERGD-25
Financials
Revenue history (in k)
From the notes
| Profit allocation | Loss to be covered |
Filing timeliness
1 of 5 financial statements was filed late (for 2021, 81 days late).
- 202502/05/2026
- 202420/04/2025
- 202326/05/2024
- 202209/07/2023
- 202104/10/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 72.02kMedianUSD 91.71kAverageUSD 1.38m
Net profit
This companyUSD -6.14kMedianUSD 2.61kAverageUSD 145.69k
Operating costs
This companyUSD 76.33kMedianUSD 82.81kAverageUSD 1.18m
Assets
This companyUSD 50.98kMedianUSD 39.25kAverageUSD 949.40k
Industry
Authorized Representatives
Paweł Dudek – Attorney-in-fact (sole)
Piotr Paweł Dudekage 24 – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Paweł Gabriel Dudekage 60 | 50 | $675.31 | 50% |
| 50 | $675.31 | 50% |
Aneta Bożena Szatkowska Dudek and Paweł Gabriel Dudek hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| LabplusS.A. | $353,375.99 | labplus.pl | ||
| WMC PietryszynS.K.A. | $305,508.46 | witamedica.pl | ||
| Kirei Clinicsp. z o.o. | $186,598.92 | kirei-clinic.pl | ||
| Kmalkosp. z o.o. | $148,877.84 | allencarr.com.pl | ||
| 8DT Klinikasp. z o.o. | $130,611.85 | 5poraroku.pl | ||
| Instytut Diagnostyki Molekularnej Diagmolsp. z o.o. | $46,278.17 | diagmol.pl | ||
| Kmnikosp. z o.o. | $36,673.53 | rzucam.to | ||
| SMD Consultingsp. z o.o. | $31,022.01 | smdgroup.pl | ||
| Esdent Diagnostykasp. z o.o. | $28,867.70 | bezpiecznatomografia.pl | ||
| Carina Caresp. z o.o. | $4,088.65 | carina-care.pl |
FAQ
The main business activity of Divi Pharma focuses on other human health activities not elsewhere classified.
The company was registered in the Polish National Court Register (KRS) on May 26, 2021.
The headquarters is located at: ul. Jerzego Bajana 7, 54-129 Wrocław.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $72,018 in 2025, which is a decrease of 15.6% compared to 2024.
No, in 2025 the company reported a net loss of $6,140.
The largest operating cost category falls under external services. This category amounted to $32,180 in 2025, representing 42% of all operating expenses.
Last updated: 2026-05-02
